Featured Jobs
|
Pentegra
|
|
Cash Balance/ Defined Benefit Plan Administrator Steidle Pension Solutions, LLC
|
|
MAP Retirement
|
|
BPAS
|
|
Retirement Plan Consultants
|
|
Retirement Plan Administration Consultant Blue Ridge Associates
|
|
Managing Director - Operations, Benefits Daybright Financial
|
|
Southern Pension Services
|
|
BPAS
|
|
Regional Vice President, Sales MAP Retirement USA LLC
|
|
Retirement Relationship Manager MAP Retirement
|
|
ESOP Administration Consultant Blue Ridge Associates
|
|
BPAS
|
|
Relationship Manager for Defined Benefit/Cash Balance Plans Daybright Financial
|
|
Anchor 3(16) Fiduciary Solutions
|
|
July Business Services
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
GLP-1 Drugs for Weight Loss: The Good, Bad and Unknown
Benefitfocus 
Sept. 5, 2025 "While covering these drugs may serve employees' needs and potentially increase satisfaction with their employee benefits package ... many employers hesitate to offer new coverage from a cost perspective alone. A 2025 article ... reports a notable increase in the average representation of GLP-1 drugs used for weight loss in total annual claims for employers, increasing from 8.9 percent in 2024 to 10.5 percent in 2025. Overall, 36 percent of employers are providing GLP-1 coverage for both diabetes and weight loss (up from 34 percent in 2024)." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |